Neutra Corp Signs Letter of Intent to Acquire CuraConnector.com, Inc., Expanding Into Healthcare Information & Digital Technology

About this update from Neutra Corp.

[{"type":"text","content":"HOUSTON, TX - April 1, 2025 (NEWMEDIAWIRE) - Neutra Corp (OTC: NTRR), a company dedicated to advancing life sciences, has executed a Letter of Intent (LOI) to acquire CuraConnector.com, Inc. in stock for stock transaction, marking a strategic move to expand into the healthcare information technology and life sciences sector. This planned acquisition aligns with Neutra Corp's evolving vision of equipping individuals with the tools necessary to make well-informed, personalized health decisions.","length":501,"tagName":"p"},{"type":"text","content":"As part of its planned continued expansion, Neutra Corp seeks to integrate innovative technologies into its portfolio, reinforcing its commitment to enhancing health and wellness solutions. The acquisition of CuraConnector.com represents a pivotal step in establishing a dedicated healthcare information technology and life sciences vertical within the company's operations, positioning itself into future macroeconomic growth sectors.","length":439,"tagName":"p"},{"type":"text","content":""This agreement reflects our commitment to advancing life sciences by leveraging healthcare information technology to empower individuals with better healthcare insights to make personal healthcare decisions," said Sydney Jim, President and CEO of Neutra Corp. "By bringing CuraConnector.com into our ecosystem, we are strengthening our ability to provide cutting-edge solutions that support informed health decisions."","length":439,"tagName":"p"},{"type":"text","content":"Nhan Nguyen, MD, JD, Chairman & Co-Founder of CuraConnector.com, expressed enthusiasm about the collaboration: "We see an incredible opportunity between CuraConnector.com and Neutra Corp. Our shared vision for empowering individuals with better healthcare choices creates a strong foundation for innovation in growing healthcare sectors. This acquisition represents a positive step in expanding the impact of personalized healthcare technology and out potential ability to raise capital for growth and expansion. We look forward to finalizing deal terms and integrating roles within the larger company structure."","length":627,"tagName":"p"},{"type":"text","content":"The LOI marks the first step in the acquisition process, with both companies working toward finalizing terms and completing due diligence. F...

More updates from Neutra Corp.